Gail Maderis brings over 20 years of management experience in healthcare to her position as President and CEO. Prior to joining FivePrime, she held various business development and general management positions at Genzyme Corporation, including founder and president of Genzyme Molecular Oncology, a publicly traded division of Genzyme, and corporate vice president of Genzyme Corporation. Previously, Ms. Maderis practiced management and strategy consulting with Bain & Co., Inc. Ms. Maderis currently serves as a board member with BayBio and is a member of the Mayor’s Biotech Advisory Council of San Francisco. She received a B.S. degree in business from the University of California at Berkeley and an M.B.A. from Harvard Business School.
